Suppression of allergic encephalomyelitis in rats by means of antibrain serum
about
Antigenized antibodies expressing Vbeta8.2 TCR peptides immunize against rat experimental allergic encephalomyelitisMyelin basic protein: structure, function and antigenic determinants.Association of autoantibodies to different nuclear antigens with clinical patterns of rheumatic disease and responsiveness to therapy.Vascular permeability changes in the central nervous system of rats with hyperacute experimental allergic encephalomyelitis induced with the aid of a substance from Bordetella pertussisSuppression of the immune response.Marek's disease as a model for the Landry--Guillain--Barré syndrome: latent viral infection in nonneuronal cells accompanied by specific immune responses to peripheral nerve and myelinReduction of allergic encephalomyelitis incubation period to five days.Experimental allergic encephalitis. Dissociation of cellular immunity to brain protein and disease production.Myelin basic protein serum factor. An endogenous neuroantigen influencing development of experimental allergic encephalomyelitis in Lewis rats.Cellular events in the induction of experimental allergic encephalomyelitis in ratsCirculating antibody to myelin basic protein in relapsing-remitting multiple sclerosis? A comparative group and sequential study by radioimmunoassay.ANTIBODY RESPONSE TO CENTRAL AND PERIPHERAL NERVE ANTIGENS IN RAT AND GUINEA-PIG.Neuroimmunologic diseases: effector cell responses and immunoregulatory mechanisms.Augmented bone loss in response to sensitization with an endogenous antigen.Approaches to the treatment of central nervous system autoimmune disease using specific neuroantigen.Treatment of inflammatory neuropathy.Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids.STUDIES ON LYSOSOMES. VII. ACUTE AND CHRONIC ARTHRITIS PRODUCED BY INTRA-ARTICULAR INJECTIONS OF STREPTOLYSIN S IN RABBITS.Correlation between strain differences in susceptibility to experimental allergic encephalomyelitis and the immune response to encephalitogenic protein in inbred guinea pigs.Immunological paradoxes: theoretical considerations in the rejection or retention of grafts, tumors, and normal tissue.Passive transfer of "allergic" encephalomyelitis with antibrain serum injected into the lateral ventricle of the brain.Phospholipid metabolism in experimental allergic encephalomyelitis: activity of brain phospholipase A1 towards specifically labelled glycerophospholipids.Lipid content in brain and spinal cord during experimental allergic encephalomyelitis in rats.Immunochemical approaches to the study of brain function and psychiatric diseases.COMPLEMENT LEVELS IN EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS.Immunological methods in psychiatric treatment.Evidence for an immunosuppressive autoantibody in experimental allergic encephalomyelitis.
P2860
Q24791647-1204D2E2-5BEF-4616-8743-E96F9A258C10Q30416785-4B3D5E5E-BD34-4830-8CB0-4681E9D324D4Q34056637-66E36C23-FC4B-4E9C-836A-A1E1DE3F348DQ34453400-50D60D68-24B8-489C-87E1-0461B657E677Q34635030-DF008FAA-59E6-4E15-A7A0-5559B12309F8Q35864140-6C419E76-603A-46E2-B194-72C97F19C4DCQ36051911-EDBE4D05-8B17-4558-A423-248B541E835EQ36271690-0CAC9D3E-7AA4-4495-AB0B-483329F4C8FDQ36342252-34F16FD6-6475-43EE-AA43-AD3D7B81863BQ36359869-7D1436A4-7DB6-43C9-B12B-78063925AFCFQ37063805-2ED144D0-CD46-40E5-B2CA-80959D35DF54Q39426984-3B33DA2E-A05A-4148-B420-4A42F9118BB7Q40100413-9B4879E1-DAF6-4F8D-82EB-3FCE40C99735Q40572594-3CD8DF7A-721F-4C8C-858F-F153720101EEQ40862395-1867E987-AD10-4B9B-B3EE-5CCC1CEB69A0Q41589697-EDB99036-989D-4B50-8DE2-8D0208CC6C16Q42499778-4FBE7D16-6EF8-4C13-B59B-17AD41A03C8DQ42538053-C2921A01-FADE-4B18-8F43-B59B021B40AFQ44878965-55769E99-D599-4E45-A42D-E996A34FD719Q47678295-6BB4AE1D-E07C-441D-83AA-0B95BFA01735Q47717194-9D7B63B6-416D-4F3A-8A74-239FA997DD8FQ48518014-7D478390-741A-40AE-97EC-D2506B72E9CAQ48779770-5D080B50-9810-4E3B-A955-4F6C5382F9C9Q48882467-2942BD7E-F746-4EDD-B28A-F8C3F4B176A4Q51274375-3BE415B0-DFC9-4FA6-B282-3C795D03254EQ52113597-56B76950-2C39-43B3-8E33-E1EF0AE9CBF0Q52126409-788CCA28-78F3-4A69-8610-1A1173D86377
P2860
Suppression of allergic encephalomyelitis in rats by means of antibrain serum
description
1963 nî lūn-bûn
@nan
1963年の論文
@ja
1963年学术文章
@wuu
1963年学术文章
@zh-cn
1963年学术文章
@zh-hans
1963年学术文章
@zh-my
1963年学术文章
@zh-sg
1963年學術文章
@yue
1963年學術文章
@zh
1963年學術文章
@zh-hant
name
Suppression of allergic encephalomyelitis in rats by means of antibrain serum
@ast
Suppression of allergic encephalomyelitis in rats by means of antibrain serum
@en
type
label
Suppression of allergic encephalomyelitis in rats by means of antibrain serum
@ast
Suppression of allergic encephalomyelitis in rats by means of antibrain serum
@en
prefLabel
Suppression of allergic encephalomyelitis in rats by means of antibrain serum
@ast
Suppression of allergic encephalomyelitis in rats by means of antibrain serum
@en
P2860
P356
P1476
Suppression of allergic encephalomyelitis in rats by means of antibrain serum
@en
P2093
PATERSON PY
P2860
P304
P356
10.1084/JEM.117.5.755
P407
P577
1963-05-01T00:00:00Z